Binding sites for blood coagulation factor Xa and protein S involving residues 493-506 in factor Va

Protein Science

Volumn 5, Issue 9, 1996, Pages 1883-1889

  Heeb, Mary J ^a   Kojima, Yumi ^b   Hackeng, Tilman M ^b   Griffin, John H ^b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

anticoagulant; blood coagulation; Factor Va; Factor Xa; protein S; protein protein interaction

Indexed keywords

BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 5A; PROTEIN S;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; BLOOD CLOTTING; BLOOD CLOTTING TIME; CARBOXY TERMINAL SEQUENCE; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTHROMBIN TIME; RESIDUE ANALYSIS;

EID: 0029833850     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1002/pro.5560050914     Document Type: Article

References (40)

1. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. 1994. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64-67
2. Dahlbäck B. 1995. Inherited thrombophilia. Resistance of activated protein C as a pathogenic factor of venous thromboembolism. Blood 85:607-614.
3. Dahlbäck B, Carlsson M, Svensson PJ. 1993 Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 90:1004-1008.
4. Dharmawardana K, Johnson AE. 1993. Dependence of factor Xa active site conformation and topography on factor Va subunits. FASEB J 7:A1191. [Abstr]
5. Fay PJ, Beattie T, Huggins CF, Regan LM. 1994. Factor VIIIa A2 subunit residues 558-565 represent a factor IXa interactive site. J Biol Chem 269: 20522-20527.
6. Greengard JS, Sun X, Xu X, Fernández JA, Griffin JH, Evatt B. 1994. Activated protein C resistance caused by Arg 506 Gln mutation in factor Va. Lancet 343:1361-1362.
7. Griffin JH, Evatt B, Wideman C, Fernández JA. 1993. Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood 82:1989-1993.
8. Guinto ER, Esmon CT 1984 Loss of prothrombin and of factor Xa-factor Va interactions upon inactivation of factor Va by activated protein C. J Biol Chem 259:13986-13992.
9. Hackeng TM, van't Veer C, Meijers JCM, Bouma BN. 1994. Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with Factors Va and Xa. J Biol Chem 269:21051-21058.
10. Heeb MJ, Chang G, Bouma B, Tans G, Griffin JH 1993a. C-terminal residues 621-635 of protein S are essential for binding to Factor Va but not Factor Xa. Thromb Haemost 69:789. [Abstr]
11. 506-factor V. Blood 85:3405-3411.
12. Heeb MJ, Kojima Y, Hackeng TM, Griffin JH. 1994a. Functional studies of factor Va residues 493-506 related to activated protein C resistance. Blood 84:391a. [Abstr]
13. Heeb MJ, Mesters RM, Tans G, Rosing J, Griffin JH. 1993b. Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C. J Biol Chem 268:2872-2877.
14. Heeb MJ, Rosing J, Bakker HM, Fernández JA, Tans G, Griffin JH. 1994b. Protein S binds to and inhibits factor Xa. Proc Natl Acad Sci USA 91:2728-2732.
15. Houghten RA. 1985. General method for the rapid solid-phase synthesis of large numbers of peptides: Specificity of antigen-antibody interaction at the level of individual amino acids Proc Natl Acad Sci USA 82:5131-5135.
16. Jane SM, Hau L, Salem HH. 1991. Regulation of activated protein C by factor Xa. Blood Coag Fibrinol 2:723-729.
17. R506Q. J Biol Chem 270:4053-4057.
18. Kalafatis M, Rand MD, Mann KG. 1994a. The mechanism of inactivation of human factor V and human factor Va by activated protein C. J Biol Chem 269:31869-31880.
19. Kalafatis M, Xue J, Lawler CM, Mann KG. 1994b. Contribution of the heavy and light chains of factor Va to the interaction with factor Xa. Biochemistry 33:6538-6545.
20. Koster T, Rosendaal FR, deRonde H, Briet E, Vandenbroucke JP, Bertina R. 1993. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study. Lancet 342:1503-1506.
21. Krishnaswamy S, Church WR, Nesheim ME, Mann KG. 1987. Activation of human prothrombin by human prothrombinase: Influence of factor Va on the reaction mechanism. J Biol Chem 262:3291-3299.
22. Krishnaswamy S, Williams EE, Mann KG. 1986. The binding of activated protein C to factors V and Va. J Biol Chem 261:9684-9693.
23. Mann KG, Nesheim ME, Hibbard LS, Tracy PB. 1981 The role of factor V in the assembly of the prothrombinase complex. In: Walz DA, McCoy LE, eds. Annals of the New York Academy of Sciences. New York: New York Academy of Sciences. pp 378-388.
24. Mesters RM, Heeb MJ, Griffin JH. 1993a. Interactions and inhibition of blood coagulation factor Va involving residues 311-325 of activated protein C. Protein Sci 2:1482-1489.
25. Mesters RM, Heeb MJ, Griffin JH. 1993b. A novel exosite in the light chain of human activated protein C essential for interaction with blood coagulation factor Va. Biochemistry 32:12656-12663.
26. Mesters RM, Houghten RA, Griffin JH. 1991. Identification of a sequence of human activated protein C (residues 390-404) essential for its anticoagulant activity. J Biol Chem 266:24514-24519.
27. R506Q by activated protein C. J Biol Chem 270:21158-21166
28. O'Brien LM, Medved LV, Fay PJ. 1995. Localization of factor IXa and factor VIIIa interactive sites. J Biol Chem 270:27087-27092.
29. Odegaard B, Mann K. 1987 Proteolysis of factor Va by factor Xa and activated protein C. J Biol Chem 262:11233-11238.
30. Pan Y, DeFay T, Gitschier J, Cohen FE. 1995. Proposed structure of the A domains of factor VIII by homology modelling. Nature Struct Biol 2:740-744.
31. R506Q by activated protein C. J Biol Chem 270:27852-27858.
32. Rosing J, Tans G, Govers-Riemslag JWP, Zwaal RFA, Hemker HC. 1980. The role of phospholipids and factor Va in the prothrombinase complex. J Biol Chem 255:274-283.
33. Solymoss S, Tucker MM, Tracy PB. 1988. Kinetics of inactivation of membrane-bound factor Va by activated protein C: Protein S modulates factor Xa protection. J Biol Chem 263:14884-14890.
34. Sun X, Evatt B, Griffin JH. 1994. Blood coagulation factor Va abnormality associated with resistance to activated protein C in venous thrombophilia. Blood 83:3120-3125.
35. Suzuki K, Stenflo JA, Dahlbäck B, Teodorsson B. 1983. Inactivation of human coagulation factor V by activated protein C J Biol Chem 258:1914-1920.
36. Svensson PJ, Dahlbäck B. 1994. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 330:517-522.
37. Tracy PB, Mann KG. 1983. Prothrombinase complex assembly on the platelet surface is mediated through the 74,000-dalton component of factor Va. Proc Natl Acad Sci USA 80:2380-2384.
38. Tucker MM, Foster WB, Katzmann JA, Mann KG 1983. A monoclonal antibody which inhibits the factor Va:factor Xa interaction. J Biol Chem 258: 1210-1214.
39. 506 of factor V. Lancet 343:1535-1536.
40. Walker FJ, Scandella D, Fay PJ. 1990. Identification of the binding site for activated protein C on the light chain of Factors V and VIII J Biol Chem 265:1484-1489.